Kristin Toftaker Killingberg
Kristin Toftaker Killingberg
Overlege kreftklinikken , Førsteamanuensis
kristin.t.killingberg@ntnu.no
Om
Overlege ved Kreftklinikken, St. Olavs hospital. Spesialist i allmennmedisin og onkologi.
PhD i medisin med tema strålebehandling av småcellet lungekreft. Forsker, førsteamanuensis.
Koordinator for praktisk klinisk eksamen ved medisinstudie NTNU (OSKE ).
Utdanning:
- Cand. med., NTNU 1996
- Spesialist i allmennmedisin 2008
- Spesialist i behandling av kreftsykdommer,Onkolog, St. Olavs Hospital 2017
- Doktorgrad (PhD i klinisk medisin), NTNU 2023
Forskningsinteresser:
- Lungekreft, spesielt småcellet lungekreft
- Strålebehandling av lungekreft
- Eldre og kreft
- Klinisk relevante biomarkører
Forskning
Hovedaktiviteten er kliniske intervensjonsstudier på lungekreft, spesielt småcellet lungekreft. Annen klinisk forskning inkluderer studier på helserelatert livskvalitet, kreft hos eldre. Den andre hovedsatsningen er translasjonsforskning basert på biologisk materiale som er samlet inn gjennom de klinsiske studiene og vår lungekreftbiobank.
Publikasjoner
2025
-
Grønberg, Miriam;
Aanerud, Marianne;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Grønberg, Bjørn Henning.
(2025)
Associations between progastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) and survival in patients with limited-stage small cell lung cancer (LS SCLC) receiving chemoradiotherapy (CRT).
Lung Cancer
Vitenskapelig artikkel
-
Graabak, Gustav;
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker.
(2025)
Changes in use of radiotherapy for lung cancer – A Norwegian population-based study from 2000 until 2020.
Lung Cancer
Vitenskapelig artikkel
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Bjaanæs, Maria Moksnes;
Brustugun, Odd Terje;
Madebo, Tesfaye;
Langer, Seppo Wang;
Risumlund, Signe Leonora;
Schytte, Tine;
Helbekkmo, Nina.
(2025)
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial.
Journal of Thoracic Oncology
Vitenskapelig artikkel
2024
-
Graabak, Gustav;
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2024)
Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC.
JTO Clinical and Research Reports
Vitenskapelig artikkel
-
Levin, Nina;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Danielsen, Signe;
Grønberg, Bjørn Henning.
(2024)
Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.
International Journal of Radiation Oncology, Biology, Physics
Vitenskapelig artikkel
-
Taranova, Evgenia;
Aanerud, Marianne;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Jordhøy, Marit Slaaen;
Grønberg, Bjørn Henning.
(2024)
Associations Between Patient-Reported Nutritional Status, Toxicity, and Survival in Limited-Stage SCLC.
JTO Clinical and Research Reports
Vitenskapelig artikkel
2023
-
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning;
Kirkevold, Øyvind;
Slaaen, Marit.
(2023)
Twice-daily thoracic radiotherapy in limited stage small-cell lung cancer.
Norges teknisk-naturvitenskapelige universitet
Doktoravhandling
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2023)
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).
American Journal of Clinical Oncology
Konferanseabstract
-
Killingberg, Kristin Toftaker;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind;
Halvorsen, Tarje Onsøien.
(2023)
Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC.
Journal of Thoracic Oncology
Vitenskapelig artikkel
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Bjaanæs, Maria Moksnes;
Madebo, Tesfaye;
Schytte, Tine;
Langer, Seppo Wang;
Risumlund, Signe Leonora;
Helbekkmo, Nina;
Neumann, Kirill.
(2023)
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).
Journal of Clinical Oncology
Konferanseabstract
-
Taranova, Evgenia;
Grønberg, Bjørn Henning;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Slaaen, Marit;
Aanerud, Marianne.
(2023)
Associations between patient-reported nutritional status, survival, and toxicity among patients with limited stage small-cell lung cancer (LS SCLC) in a randomized trial of high-dose, twice-daily (BID) thoracic radiotherapy (TRT).
Journal of Clinical Oncology
Konferanseabstract
2022
-
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Fløtten, Øystein;
Brustugun, Odd Terje;
Langer, Seppo W.;
Nyman, Jan;
Hornslien, KJERSTI;
Madebo, Tesfaye;
Schytte, Tine;
Risum, Signe.
(2022)
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Lung Cancer
Vitenskapelig artikkel
-
Stokke, Kristin;
Sandvei, Marie Søfteland;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2022)
Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer.
Clinical Medicine Insights: Oncology
Vitenskapelig artikkel
-
Levin, Nina;
Danielsen, Signe;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Redalen, Kathrine Røe;
Grønberg, Bjørn Henning.
(2022)
Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer.
Radiotherapy and Oncology
Konferanseabstract
-
Stokke, Kristin;
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning;
Saltvedt, Ingvild;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind;
Killingberg, Kristin Toftaker;
Sandvei, Marie Søfteland.
(2022)
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.
Healthcare
Vitenskapelig artikkel
2021
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Brustugun, Odd;
Hornslien, KJERSTI;
Madebo, Tesfaye;
Langer, Seppo Wang;
Schytte, Tine;
Nyman, Jan;
Risum, Signe.
(2021)
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
The Lancet Oncology
Vitenskapelig artikkel
2020
-
Halvorsen, Tarje Onsøien;
Stokke, Kristin;
Killingberg, Kristin Toftaker;
Raj, Sunil Xavier;
Sørhaug, Sveinung;
Brustugun, Odd Terje;
Fløtten, Øystein;
Helbekkmo, Nina;
Hornslien, Kjersti;
Madebo, Tesfaye.
(2020)
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC.
Acta Oncologica
Vitenskapelig artikkel
Tidsskriftspublikasjoner
-
Grønberg, Miriam;
Aanerud, Marianne;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Grønberg, Bjørn Henning.
(2025)
Associations between progastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) and survival in patients with limited-stage small cell lung cancer (LS SCLC) receiving chemoradiotherapy (CRT).
Lung Cancer
Vitenskapelig artikkel
-
Graabak, Gustav;
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker.
(2025)
Changes in use of radiotherapy for lung cancer – A Norwegian population-based study from 2000 until 2020.
Lung Cancer
Vitenskapelig artikkel
-
Graabak, Gustav;
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2024)
Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC.
JTO Clinical and Research Reports
Vitenskapelig artikkel
-
Levin, Nina;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Danielsen, Signe;
Grønberg, Bjørn Henning.
(2024)
Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.
International Journal of Radiation Oncology, Biology, Physics
Vitenskapelig artikkel
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2023)
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).
American Journal of Clinical Oncology
Konferanseabstract
-
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Fløtten, Øystein;
Brustugun, Odd Terje;
Langer, Seppo W.;
Nyman, Jan;
Hornslien, KJERSTI;
Madebo, Tesfaye;
Schytte, Tine;
Risum, Signe.
(2022)
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Lung Cancer
Vitenskapelig artikkel
-
Stokke, Kristin;
Sandvei, Marie Søfteland;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2022)
Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer.
Clinical Medicine Insights: Oncology
Vitenskapelig artikkel
-
Killingberg, Kristin Toftaker;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind;
Halvorsen, Tarje Onsøien.
(2023)
Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC.
Journal of Thoracic Oncology
Vitenskapelig artikkel
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Bjaanæs, Maria Moksnes;
Madebo, Tesfaye;
Schytte, Tine;
Langer, Seppo Wang;
Risumlund, Signe Leonora;
Helbekkmo, Nina;
Neumann, Kirill.
(2023)
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).
Journal of Clinical Oncology
Konferanseabstract
-
Taranova, Evgenia;
Aanerud, Marianne;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Jordhøy, Marit Slaaen;
Grønberg, Bjørn Henning.
(2024)
Associations Between Patient-Reported Nutritional Status, Toxicity, and Survival in Limited-Stage SCLC.
JTO Clinical and Research Reports
Vitenskapelig artikkel
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Brustugun, Odd;
Hornslien, KJERSTI;
Madebo, Tesfaye;
Langer, Seppo Wang;
Schytte, Tine;
Nyman, Jan;
Risum, Signe.
(2021)
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
The Lancet Oncology
Vitenskapelig artikkel
-
Taranova, Evgenia;
Grønberg, Bjørn Henning;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Slaaen, Marit;
Aanerud, Marianne.
(2023)
Associations between patient-reported nutritional status, survival, and toxicity among patients with limited stage small-cell lung cancer (LS SCLC) in a randomized trial of high-dose, twice-daily (BID) thoracic radiotherapy (TRT).
Journal of Clinical Oncology
Konferanseabstract
-
Levin, Nina;
Danielsen, Signe;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Redalen, Kathrine Røe;
Grønberg, Bjørn Henning.
(2022)
Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer.
Radiotherapy and Oncology
Konferanseabstract
-
Halvorsen, Tarje Onsøien;
Stokke, Kristin;
Killingberg, Kristin Toftaker;
Raj, Sunil Xavier;
Sørhaug, Sveinung;
Brustugun, Odd Terje;
Fløtten, Øystein;
Helbekkmo, Nina;
Hornslien, Kjersti;
Madebo, Tesfaye.
(2020)
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC.
Acta Oncologica
Vitenskapelig artikkel
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Bjaanæs, Maria Moksnes;
Brustugun, Odd Terje;
Madebo, Tesfaye;
Langer, Seppo Wang;
Risumlund, Signe Leonora;
Schytte, Tine;
Helbekkmo, Nina.
(2025)
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial.
Journal of Thoracic Oncology
Vitenskapelig artikkel
-
Stokke, Kristin;
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning;
Saltvedt, Ingvild;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind;
Killingberg, Kristin Toftaker;
Sandvei, Marie Søfteland.
(2022)
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.
Healthcare
Vitenskapelig artikkel
Studentoppgave eller avhandling
-
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning;
Kirkevold, Øyvind;
Slaaen, Marit.
(2023)
Twice-daily thoracic radiotherapy in limited stage small-cell lung cancer.
Norges teknisk-naturvitenskapelige universitet
Doktoravhandling
Formidling
2025
-
KonferanseposterKillingberg, Kristin Toftaker; Sætrom, Pål; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Figueiredo, Filipe Carlos Pereira dos Reis. (2025) Serum microRNAs are associated with treatment response and disease progression in limited stage small cell lung cancer. IASLC Hot topic in basic and translational science small cell lung cancer
-
ForedragGrønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Sandvei, Marie Søfteland. (2025) Randomized phase II trial investigating whether atezolizumab after chemoradiotherapy (CRT) prolongs survival in limited stage (LS) small cell lung cancer (SCLC). ASCO 2025
-
KonferanseposterGrønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Oliveira, Rafael S.. (2025) Subtyping Small Cell Lung Cancer Reveals Inflammatory Subtypes with Improved Radiosensitivity and Chemoradiotherapy Outcomes. IASLC Hot topic in basic and translational science small cell lung cancer
-
KonferanseposterGrønberg, Miriam; Killingberg, Kristin Toftaker; Aanerud, Marianne; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning. (2025) Time Until Treatment, Treatment Time, and Outcomes of Chemoradiotherapy in Limited Stage Small Cell Lung Cancer. European Lung Cancer Congress 2025
2023
-
ForedragGrønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). ASCO 2023
-
ForedragLevin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2023) Dose-response of acute esophagitis for limited stage small cell lung cancer - Data from a randomized phase II trial. BiGART
2022
-
ForedragLevin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2022) Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer. ESTRO 2022
2019
-
KonferanseposterStokke, Kristin; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Sørhaug, Sveinung; Madebo, Tesfaye; Raj, Sunil Xavier; Killingberg, Kristin Toftaker; Fluge, Sverre; Hornslien, KJERSTI; Grønberg, Bjørn Henning. (2019) Randomized phase III trial comparing maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Verdenskonferansen for lungekreft, WCLC